Eledon Pharmaceuticals
ELDN
ELDN
35 hedge funds and large institutions have $52.1M invested in Eledon Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
+1
Holders Change %
+2.94%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
10
Reduced
12
Closed
4
Calls
$80K
Puts
–
Net Calls
+$80K
Net Calls Change
+$80K
Top Buyers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.85M |
2 |
BI
BVF Inc
San Francisco,
California
|
+$1.54M |
3 |
EP
Eversept Partners
New York
|
+$705K |
4 |
Two Sigma Investments
New York
|
+$357K |
5 |
Two Sigma Advisers
New York
|
+$232K |
Top Sellers
1 |
Morgan Stanley
New York
|
-$4.59M |
2 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
-$2.74M |
3 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$2.13M |
4 |
Janus Henderson Group
London,
United Kingdom
|
-$1.93M |
5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$682K |